Kansas City Cancer Center South

Kansas City, Missouri 64131

0 studies enrolling now · 10 studies all time

What they study most

Adenocarcinoma of the Gastroesophageal Junction, Breast Cancer, Cervical Cancer, Diffuse Gastric Adenocarcinoma, Esophageal Cancer, Gastric Cancer, Gastric Intestinal Type Adenocarcinoma, Gastric Mixed Adenocarcinoma, Kidney Cancer, Prostate Cancer, Recurrent Gastric Carcinoma, Recurrent Large Cell Lung Carcinoma

Studies at this site

• Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer — Completed
• Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer — Completed
• Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer — Completed
• Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy — Completed
• S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery — Completed
• S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer — Stopped early
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer — Completed
• Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer — Completed
• A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer — Stopped early